COMMUNIQUÉS West-GlobeNewswire
-
Innovation Pharmaceuticals Announces $7 million Milestone Funding Agreement with Aspire Capital
28/06/2018 - 22:30 -
Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers
28/06/2018 - 22:30 -
Biogen Exercises Option to Increase Ownership in Samsung Bioepis
28/06/2018 - 22:06 -
TESARO Enters Asset Purchase Agreement with TerSera® Therapeutics LLC for VARUBI® in the U.S. and Canada
28/06/2018 - 22:05 -
electroCore to Present Additional Research for Non-invasive Vagus Nerve Stimulation (nVNS) in Headache Disorders at the 60th Annual Meeting of the American Headache Society
28/06/2018 - 22:01 -
Ziopharm Oncology Enrolls First Patient in Phase 1 Trial Evaluating Combination Therapy of Controlled IL-12 and OPDIVO®
28/06/2018 - 22:01 -
MAC Clinical Research Announces Presentation at the 60th Annual Scientific Meeting of the American Headache Society
28/06/2018 - 22:01 -
Gemcabene Meets Primary Endpoint in INDIGO-1 Study of Severe Hypertriglyceridemia (SHTG) Patients
28/06/2018 - 22:01 -
Trevena announces successful completion of Phase 1 study of TRV250 for acute migraine
28/06/2018 - 22:01 -
ALRT announces launch of the Integrated ALRT Diabetes Solution (“Integrated Solution”)
28/06/2018 - 21:58 -
CAPS® Expert Appointed to the Board of Pharmacy Specialties’ Council
28/06/2018 - 20:50 -
League and Molecular You Partner to Provide Employees with Personalized Health Assessments for Early Detection and Preventive Healthcare
28/06/2018 - 18:30 -
NeuroMetrix PR Campaign Wins Gold at the Publicity Club of New England 2018 Bell Ringer Awards
28/06/2018 - 18:27 -
NEOVACS : SUSPENSION DE COURS
28/06/2018 - 18:01 -
Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offerings in the U.S.
28/06/2018 - 18:01 -
electroCore, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering
28/06/2018 - 17:45 -
Medtronic Launches the MiniMed(TM) 670G System Performance Guarantee for Payers and Employers
28/06/2018 - 17:37 -
Tivity Health to Issue Second Quarter 2018 Financial Results After Market Close on August 2
28/06/2018 - 17:00 -
Meridian Bioscience, Inc. Expects to Report Third Quarter Fiscal Year 2018 Operating Results on Tuesday, July 31, 2018
28/06/2018 - 17:00
Pages